Failed lung cancer drug trial sends Bristol Myers stock plunging and Merck’s shares up By: MarketWatch August 05, 2016 at 08:53 AM EDT Merck has a rival lung cancer drug. Read More >> Related Stocks: Bristol-Myers Squibb Merck & Co